Pediatric Catheter Market (2026 - 2033)

Pediatric Catheter Market Summary

The global pediatric catheter market size was valued at USD 8.5 billion in 2025 and is projected to grow from USD 9.3 billion in 2026 to USD 17.0 billion by 2033, at a CAGR of 9.1% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.0% in 2025. Growth in the pediatric population, rising rates of congenital heart defects (CHD), neurological disorders, and urinary tract infections, and a lack of adequate newborn screening centers in emerging countries are some of the factors driving demand for pediatric catheters.

Moreover, the increasing incidence of cardiovascular and urological conditions among pediatric patients is driving demand for minimally invasive diagnostic and therapeutic procedures, including specialized catheters. Technological advancements in pediatric catheter design, including improved materials, antimicrobial properties, and enhanced biocompatibility, are helping reduce the risk of catheter-associated infections and complications. These innovations are expected to support the broader adoption of pediatric catheters over the forecast period.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Analyst Perspective

The global pediatric catheter market is growing steadily, driven by congenital heart defects, urological disorders, and chronic conditions requiring catheter-based care. Greater awareness of early diagnosis and improved pediatric healthcare infrastructure are boosting adoption of specialized catheters designed for infants and children. Advances in antimicrobial coatings, improved biocompatible materials, and safer designs also support growth. Further investment and expansion of neonatal and pediatric intensive care units are expected to create opportunities over the forecast period.

Product Insights

The cardiovascular catheters segment dominated the market, accounting for around 40.0% of revenue in 2025. Congenital heart defects pose a significant threat to the survival of pediatric patients, contributing to a high mortality rate within this population. One crucial factor driving this trend is the availability of a diverse array of catheters for various interventional cardiology procedures. These catheters play a pivotal role in addressing the challenges posed by congenital heart defects, thereby influencing the segment's growth and impact on patient outcomes. Pediatric catheters are used to address the issues associated with catheterization in children. The design of pediatric catheters is unique, and they are frequently made from different materials. These help in the treatment of dysfunctional bladders caused by spinal cord damage, spina bifida, diabetes, stroke, Parkinson's disease, or incontinence. Due to the increased number of venous thromboembolism (VTE) in the pediatric population, the use of these devices has expanded globally. The ease of installation and low cost of these catheters are anticipated to drive the market demand. Instances of alcohol and drug abuse during pregnancy are on the rise, raising the risk of congenital cardiovascular problems in newborns. Its prevalence is also linked to genetic predisposition.

The urology catheters segment is expected to grow at the fastest CAGR from 2026 to 2033. This growth will be driven by the increasing prevalence of bladder, urethra, uterus, and kidney problems in the pediatric population. Urology catheters are thin, hollow, plastic tubes used to drain urine from the bladder. The catheter is inserted into the bladder through the urethra. It is often used after operations for the urinary system, as it allows the healing process. It aids in treatments for the kidneys, bladder, urethra, and reproductive organs. Discomfort related to the catheterization of the urinary tract is minimized by using the appropriate catheter size in the pediatric population.

The use of catheters and their appropriate size varies with the age group of children. Thus, the increasing prevalence of urological diseases, such as urinary tract infections in infants, is driving the pediatric catheter market. Other products, such as neurovascular, intravenous, and specialty catheters, are also anticipated to expand at a high CAGR owing to the increasing incidence of corresponding diseases in children, which require the use of these catheters for diagnosis and treatment.

Regional Insights

North America pediatric catheter market dominated the pediatric catheter market, accounting for 35.0% of revenue in 2025. The region's leadership is supported by the high prevalence of congenital heart defects and urological conditions among children, the availability of advanced pediatric healthcare infrastructure, and the high volume of inpatient and emergency procedures. In addition, favorable healthcare coverage and reimbursement policies support access to pediatric diagnostic and therapeutic procedures. In the U.S., programs such as the Children's Health Insurance Program (CHIP) provide health coverage to eligible children from low-income families, supporting access to pediatric healthcare services.

To learn more about this report, Download Free Sample Report

The region's well-established network of specialized children's hospitals, neonatal and pediatric intensive care units, and pediatric cardiac centers is expected to support demand for specialized catheter products. According to the U.S. CDC, congenital heart defects affect nearly 1% of births, corresponding to approximately 40,000 babies annually in the U.S. Moreover, about one in four babies born with a heart defect has a critical congenital heart defect, with affected infants generally requiring surgery or other medical procedures during the first year of life. These factors, together with continued advances in minimally invasive pediatric procedures and catheter technologies, are expected to support market growth in North America over the forecast period

Asia Pacific Pediatric Catheter Market Trends

Asia Pacific is anticipated to register the fastest CAGR from 2026 to 2033, driven by the increasing burden of congenital heart defects and other pediatric conditions, the expansion of public and private healthcare infrastructure, and improved access to specialized diagnostic and interventional procedures. The region also has a substantial unmet need for pediatric cardiovascular and urological care, particularly across emerging economies.

Congenital heart defects represent an important pediatric healthcare burden in the region. Published evidence indicates that Asia has one of the highest reported CHD birth prevalences globally, at approximately 9.3 cases per 1,000 live births, although prevalence varies considerably across countries and is influenced by differences in screening and diagnostic capabilities. The large pediatric populations and high birth rates in countries such as China and India further increase the potential patient pool.

Key Pediatric Catheter Market Company Insights

Market participants are pursuing organic and inorganic growth strategies, including product portfolio expansion, strategic collaborations, acquisitions, and technological innovation, to strengthen their market positions. Companies are increasingly focusing on developing specialized pediatric devices that address the anatomical and clinical requirements of neonates and children. Advances in catheter materials, miniaturization, antimicrobial technologies, and minimally invasive delivery systems are expected to intensify competition and create opportunities for market participants over the forecast period.

Key Pediatric Catheter Companies

The following key companies have been profiled for this study on the pediatric catheter market.

• BD

• Boston Scientific Corporation

• Coloplast Group

• Cook Group Incorporated

• Edwards Lifesciences Corporation

• Getinge

• ICU Medical, Inc.

• Johnson & Johnson Medical Pty Ltd.

• Medtronic

Recent Developments

• In June 2026, Spectrum Vascular acquired Piccolo Medical to accelerate the development and commercialization of next-generation catheter navigation and guidance technologies. The acquisition strengthens Spectrum Vascular's vascular-access portfolio and expands its capabilities in catheter guidance and tip-location technologies.

• In September 2024, Piccolo Medical received FDA 510(k) clearance for its PM2 System with ECGuide Connector, a catheter guidance technology that uses the patient's cardiac electrical activity to provide real-time catheter-tip location information. The system was cleared as an alternative to chest X-ray or fluoroscopy for confirming central venous catheter placement.

Global Pediatric Catheter Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pediatric catheter market report based on product and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)

  • Cardiovascular Catheters

  • Urology Catheters

  • Intravenous Catheters

  • Neurovascular Catheters

  • Specialty Catheters

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Russia

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Singapore

    • South Korea

  • Central & South America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE